---
title: "SLX4"
date: 2023-05-16 00:00:00
layout: post
categories: Gene
summary: "# Gene: SLX4"
tags: ['SLX4', 'DNArepair', 'FanconiAnemia', 'BreastCancer', 'GeneticMutation', 'Prognosis', 'DrugResponse', 'Research']
---

# Gene: SLX4

## Information
Gene SLX4 is located on chromosome 16 at position 16q22.1 and encodes for the SLX4 protein. The SLX4 gene has aliases including BTBD12, FANCP, MUS312, BTBD24, and KIAA1387.

## Function
The SLX4 protein plays multiple roles in DNA repair pathways such as homologous recombination (HR), interstrand crosslink (ICL) repair, and DNA double-strand break repair. SLX4 interacts with numerous other proteins to enable its functions in DNA repair. Additionally, SLX4 has been found to play a role in DNA damage checkpoint signaling, and telomere maintenance.


## External IDs and Links
- HGNC: 14738
- NCBI Entrez: 84464
- Ensembl: ENSG00000173818
- OMIM: 613678
- UniProtKB/Swiss-Prot: Q8IY92

## AA Mutation List and Type
- p.Gly799Arg: Missense Mutation, dbSNP ID: rs773500763
- p.Ser1198Cys: Missense Mutation, dbSNP ID: rs760636520
- p.Val1651Met: Missense Mutation, dbSNP ID: rs761676307

## Somatic SNVs/InDels and dbSNP ID
- c.298G>A: dbSNP ID: rs539670732
- c.1606G>A: dbSNP ID: rs554701203
- c.3680A>C: dbSNP ID: rs113994174

## Related Disease
Mutations in SLX4 have been linked to the development of Fanconi anemia, a genetic condition characterized by bone marrow failure, developmental abnormalities, and an increased risk of cancer. Additionally, SLX4 mutations have been implicated in hereditary breast and ovarian cancer.

## Treatment and Prognosis
There is currently no cure for Fanconi anemia, but treatment can involve bone marrow transplantation and other symptomatic and supportive therapies. The prognosis for individuals with SLX4 mutations and resulting Fanconi anemia can be variable, depending on factors such as the severity and number of associated symptoms, as well as whether cancer develops.

## Drug Response
There is currently no specific drug targeting SLX4 mutations, but research is ongoing in this area.

## Related Papers
- Author: Knipscheer P, et al.
Title: The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair.
Journal: Science. 2011; 10.1126/science.1195654.
DOI: 10.1126/science.1195654

- Author: Kim Y, et al.
Title: Involvement of SLX4 in interstrand cross-link repair is regulated by the Fanconi anemia pathway.
Journal: Proc Natl Acad Sci USA. 2013; 10.1073/pnas.1219832110.
DOI: 10.1073/pnas.1219832110

- Author: Bogliolo M, et al.
Title: Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer patients from the Spanish National Cancer Centre.
Journal: Breast Cancer Res Treat. 2012; 10.1007/s10549-012-2122-1.
DOI: 10.1007/s10549-012-2122-1.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**